Search Results - "Ghezelayagh, S"

Minimising aseptic loosening in extreme bone resections: custom-made tumour endoprostheses with short medullary stems and extra-cortical plates by Stevenson, J D, Wigley, C, Burton, H, Ghezelayagh, S, Morris, G, Evans, S, Parry, M, Jeys, L

“…Following the resection of an extensive amount of bone in the treatment of a tumour, the residual segment may be insufficient to accept a standard length…”
Get more information

Antiprogestins reduce epigenetic field cancerization in breast tissue of young healthy women by Bartlett, Thomas E, Evans, Iona, Jones, Allison, Barrett, James E, Haran, Shaun, Reisel, Daniel, Papaikonomou, Kiriaki, Jones, Louise, Herzog, Chiara, Pashayan, Nora, Simões, Bruno M, Clarke, Robert B, Evans, D Gareth, Ghezelayagh, Talayeh S, Ponandai-Srinivasan, Sakthivignesh, Boggavarapu, Nageswara R, Lalitkumar, Parameswaran G, Howell, Sacha J, Risques, Rosa Ana, Rådestad, Angelique Flöter, Dubeau, Louis, Gemzell-Danielsson, Kristina, Widschwendter, Martin

“…Breast cancer is a leading cause of death in premenopausal women. Progesterone drives expansion of luminal progenitor cells, leading to the development of…”
Get full text

Correction: Antiprogestins reduce epigenetic field cancerization in breast tissue of young healthy women by Bartlett, Thomas E, Evans, Iona, Jones, Allison, Barrett, James E, Haran, Shaun, Reisel, Daniel, Papaikonomou, Kiriaki, Jones, Louise, Herzog, Chiara, Pashayan, Nora, Simões, Bruno M, Clarke, Robert B, Evans, D Gareth, Ghezelayagh, Talayeh S, Ponandai-Srinivasan, Sakthivignesh, Boggavarapu, Nageswara R, Lalitkumar, Parameswaran G, Howell, Sacha J, Risques, Rosa Ana, Rådestad, Angelique Flöter, Dubeau, Louis, Gemzell-Danielsson, Kristina, Widschwendter, Martin

Get full text

TP53 somatic evolution in cervical liquid-based cytology and blood from individuals with and without ovarian cancer and BRCA1 or BRCA2 germline mutations by Ghezelayagh, Talayeh S., Kohrn, Brendan F., Fredrickson, Jeanne, Krimmel-Morrison, Jeffrey D., Latorre-Esteves, Elena, Tee, Xin-Ray, Radke, Marc R., Manhardt, Enna, Norquist, Barbara M., Katz, Ronit, Swisher, Elizabeth M., Risques, Rosa Ana

“…Somatic TP53 mutations are prevalent in normal tissue but little is known about their association with cancer risk. Cervical liquid-based cytology (LBC),…”
Get full text

Increased TP53 somatic evolution in peritoneal washes of individuals with BRCA1 germline mutations by Tee, Xin Ray, Hazard, Emma, Latorre-Esteves, Elena, Kohrn, Brendan F., Ghezelayagh, Talayeh S., Fredrickson, Jeanne Uy, Coombes, CoohleenAnn, Radke, Marc R., Manhardt, Enna, Katz, Ronit, Soong, T. Rinda, Swisher, Elizabeth M., Norquist, Barbara M., Risques, Rosa Ana

“…Individuals with germline BRCA1 and BRCA2 pathogenic variants (BRCA carriers) are at high risk of developing high grade serous ovarian carcinoma (HGSC). HGSC…”
Get full text

Characterizing TP53 mutations in ovarian carcinomas with and without concurrent BRCA1 or BRCA2 mutations by Ghezelayagh, Talayeh S., Pennington, Kathryn P., Norquist, Barbara M., Khasnavis, Nithisha, Radke, Marc R., Kilgore, Mark R., Garcia, Rochelle L., Lee, Ming, Katz, Ronit, Leslie, Kimberly K., Risques, Rosa Ana, Swisher, Elizabeth M.

“…Mutations in the TP53 tumor suppressor gene are common in ovarian carcinoma (OC) but their impact on outcomes is controversial. We sought to define the…”
Get full text

Characterization of TP53 mutations in Pap test DNA of women with and without serous ovarian carcinoma by Krimmel-Morrison, Jeffrey D., Ghezelayagh, Talayeh S., Lian, Shenyi, Zhang, Yuezheng, Fredrickson, Jeanne, Nachmanson, Daniela, Baker, Kathryn T., Radke, Marc R., Hun, Enna, Norquist, Barbara M., Emond, Mary J., Swisher, Elizabeth M., Risques, Rosa Ana

“…Pap tests hold promise as a molecular diagnostic for serous ovarian cancer, but previous studies reported limited sensitivity. Furthermore, the presence of…”
Get full text

Perceptions of risk and reward in BRCA1 and BRCA2 mutation carriers choosing salpingectomy for ovarian cancer prevention by Ghezelayagh, Talayeh S., Stewart, Lauren E., Norquist, Barbara M., Bowen, Deborah J., Yu, Vivian, Agnew, Kathy J., Pennington, Kathryn P., Swisher, Elizabeth M.

“…Salpingectomy with interval oophorectomy has gained traction as an ovarian cancer prevention strategy, but is not currently recommended for high risk women…”
Get full text

Uterine lavage identifies cancer mutations and increased TP53 somatic mutation burden in individuals with ovarian cancer by Ghezelayagh, Talayeh S, Kohrn, Brendan F, Fredrickson, Jeanne, Manhardt, Enna, Radke, Marc R, Katz, Ronit, Gray, Heidi J, Urban, Renata R, Pennington, Kathryn P, Liao, John B, Doll, Kemi M, Simons, Elise J, Burzawa, Jennifer K, Goff, Barbara A, Speiser, Paul, Swisher, Elizabeth M, Norquist, Barbara M, Risques, Rosa Ana

“…Current screening methods for ovarian cancer (OC) have failed to demonstrate a significant reduction in mortality. Uterine lavage combined with ultra-deep…”
Get full text

Minimising aseptic loosening in extreme boneresections: custom-made tumour endoprostheses with short medullary stems and extra-cortical plates by Stevenson, J D, Wigley, C, Burton, H, Ghezelayagh, S, Morris, G, Evans, S, Parry, M, Jeys, L

“…AimsFollowing the resection of an extensive amount of bone in thetreatment of a tumour, the residual segment may be insufficientto accept a standard length…”
Get full text

Antiprogestins reduce epigenetic field cancerization in breast tissue of young healthy women (vol 14, 64, 2022) by Bartlett, TE, Evans, I, Jones, A, Barrett, JE, Haran, S, Reisel, D, Papaikonomou, K, Jones, L, Herzog, C, Pashayan, N

Get full text